Evidence map›Paper›PMID 29168936›Full record

ArticleDento maxillo facial radiology2018

Does CBCT alter the diagnostic thinking efficacy, management and prognosis of patients with suspected Stage 0 medication-related osteonecrosis of the jaws?

Hiroaki Shimamoto, Tristan R Grogan, Tomomi Tsujimoto, Naoya Kakimoto, Shumei Murakami, David Elashoff, Tara L Aghaloo, Sotirios Tetradis

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Dento maxillo facial radiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hiroaki Shimamoto1 Department of Oral and Maxillofacial Radiology, Osaka University Graduate School of Dentistry , Suita, Osaka , Japan.
Tristan R Grogan3 Statistics Core, David Geffen School of Medicine, University of California Los Angeles , Los Angeles, CA , USA.
Tomomi Tsujimoto1 Department of Oral and Maxillofacial Radiology, Osaka University Graduate School of Dentistry , Suita, Osaka , Japan.
Naoya Kakimoto4 Department of Oral and Maxillofacial Radiology, Institute of Biomedical & Health Sciences, Hiroshima University , Minami-ku, Hiroshima , Japan.
Shumei Murakami1 Department of Oral and Maxillofacial Radiology, Osaka University Graduate School of Dentistry , Suita, Osaka , Japan.
David Elashoff3 Statistics Core, David Geffen School of Medicine, University of California Los Angeles , Los Angeles, CA , USA.
Tara L Aghaloo5 Section of Oral and Maxillofacial Surgery, UCLA, School of Dentistry , Los Angeles, CA , USA.
Sotirios Tetradis2 Section of Oral and Maxillofacial Radiology, UCLA School of Dentistry , Los Angeles, CA , USA.

Funding

Pathophysiologic Mechanisms of Bisphosphonate Related Osteonecrosis of the JawsR01DE019465 · NIDCR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TETRADIS, SOTIRIOS · 2009 to 2024
$5.4M
NIDCR NIH HHS R01 DE019465
6 · The paper itself

Abstract

objectivesTo evaluate the impact of cone beam CT (CBCT) in the diagnostic thinking efficacy, management and prognosis of patients with suspected Stage 0 medication-related osteonecrosis of the jaw (MRONJ).

methodsFor 15 patients with suspected Stage 0 MRONJ, clinical photographs, a panoramic radiograph and selected CBCT sections were identified. 13 oral surgeons reviewed the material and answered 10 questions in two different sessions. First session included clinical photographs and panoramic radiographs, while second session also included CBCT images. Questions (Qs) referred to dental disease and bone abnormalities (Qs 1, 2 and 3), differential diagnosis (Qs 4 and 5), patient management (Qs 6 and 7) and prognosis (Qs 8 and 9). Q 10 queried indication (first session) and usefulness (second session) of CBCT images.

resultsQs 2, 3, 5, 7 and 9 scores increased between sessions, with statistical differences for Qs 2, 3, 5 and 7 (<0.05). Patients 2, 8 and 11 showed a significant increase in the average score of all Qs between sessions, while scores for patient 10 nearly reached statistical significance (p = 0.055). For Q 10, 57.4% of answers reported that CBCT was needed (first session) and was beneficial (second session).

conclusionsCBCT had a significant impact in differential diagnosis and management of patients with suspected Stage 0 MRONJ.

Indexed as

Cone-Beam Computed TomographyClinical Decision-MakingHumansOsteonecrosisPrognosisSelf ReportSeverity of Illness Index

Identifiers

PMID29168936
PMCPMC6047633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.